NCT02514915: Pre-operative Stereotactic Radiosurgery Followed by Resection for Brain Metastases

NCT02514915
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Active, not recruiting
Phase 2
Drug Category: Radiation therapy

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: Brain
Additional Notes: Patient must have at least 1 target lesion that measures at least 15 mm in one dimension and is recommended for surgical removal
Exclusions: Patients with more than 4 distinct lesions in the brain
https://ClinicalTrials.gov/show/NCT02514915

Comments are closed.

Up ↑